Emcure Pharmaceuticals, backed by Namita Thapar, made a remarkable debut on the Indian stock exchanges on Wednesday, July 10. The shares were listed at ₹1,325.05 apiece on the BSE, reflecting a 31.45 percent premium over the issue price of ₹1,008. Following the listing, Emcure Pharma’s shares climbed further to ₹1,384, […]
Emcure Pharma
These three funds held a collective ₹5 trillion, or nearly $60 billion, in Indian stocks as of 31 March, show data compiled by Mint. Of that, about ₹2.57 trillion (about $30 billion) was invested over the previous three financial years (2021-22 to 2023-24). Sovereign funds are doubling down on India at […]
Stock market investors have shown a powerful response to Emcure Pharmaceuticals Limited’s initial public offering (IPO), with all three categories—Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Investors—displaying robust bidding figures on the third day of the offering. According to data from the Bombay Stock Exchange (BSE) website, the […]